CN Patent

CN105026030B — 充气微泡

Assigned to Bracco Suisse SA · Expires 2017-04-12 · 9y expired

What this patent protects

用于制备充气微泡的制剂，所述制剂包括一种磷脂与一种饱和和不饱和脂肪酸的混合物。相对于仅包含一种饱和或一种不饱和脂肪酸的微泡，具有包含所述成分的稳定化层的充气微泡显示出增加的稳定性。

USPTO Abstract

用于制备充气微泡的制剂，所述制剂包括一种磷脂与一种饱和和不饱和脂肪酸的混合物。相对于仅包含一种饱和或一种不饱和脂肪酸的微泡，具有包含所述成分的稳定化层的充气微泡显示出增加的稳定性。

Drugs covered by this patent

sulfur-hexafluoride-lipid-type-a-microspheres (Sulfur hexafluoride lipid-type A microspheres) · Children's Hospital of Philadelphia

Patent Metadata

Patent number: CN105026030B
Jurisdiction: CN
Classification: —
Expires: 2017-04-12
Drug substance claim: No
Drug product claim: No
Assignee: Bracco Suisse SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.